Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDER'S DEFICIT (unaudited)

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDER'S DEFICIT (unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 323,182 $ 117,373,818 $ (121,204,000) $ (3,507,000)
Balance at beginning, shares at Dec. 31, 2020 323,181,243      
Adjustment for adoption of ASU 2020-06 (60,000) 30,000 (30,000)
Common stock issued on conversion of notes payable $ 15,618 316,382 332,000
Common stock issued on conversion of notes payable, shares 15,617,653      
Warrants issued with convertible notes 156,000 156,000
Fair value of options and warrants issued as compensation 41,000 41,000
Issuance of common stock for cash $ 8,533 119,467 128,000
Issuance of common stock for cash, shares 8,533,333      
Net loss (1,168,000) (1,168,000)
Ending balance, value at Sep. 30, 2021 $ 347,333 117,946,667 (122,342,000) (4,048,000)
Balance at ending, shares at Sep. 30, 2021 347,332,229      
Beginning balance, value at Jun. 30, 2021 $ 338,111 117,676,889 (121,819,000) (3,804,000)
Balance at beginning, shares at Jun. 30, 2021 338,110,564      
Common stock issued on conversion of notes payable $ 9,222 189,778 199,000
Common stock issued on conversion of notes payable, shares 9,221,665      
Warrants issued with convertible notes 57,000 57,000
Fair value of options and warrants issued as compensation 23,000 23,000
Issuance of common stock for cash
Net loss (523,000) (523,000)
Ending balance, value at Sep. 30, 2021 $ 347,333 117,946,667 (122,342,000) (4,048,000)
Balance at ending, shares at Sep. 30, 2021 347,332,229      
Beginning balance, value at Dec. 31, 2021 $ 355,301 118,065,699 (122,594,000) (4,173,000)
Balance at beginning, shares at Dec. 31, 2021 355,300,222      
Common stock issued on conversion of notes payable $ 1,931 18,069 20,000
Common stock issued on conversion of notes payable, shares 1,930,633      
Warrants issued with convertible notes 283,000 283,000
Common stock issued on exercise of warrants $ 8,594 297,406 306,000
Common stock issued on exercise of warrants, shares 8,593,828      
Fair value of options and warrants issued as compensation 31,000 31,000
Common stock issued on exercise of options $ 250 19,750 20,000
Common stock issued on exercise of options, shares 250,000      
Net loss (909,000) (909,000)
Ending balance, value at Sep. 30, 2022 $ 366,076 118,714,924 (123,503,000) (4,422,000)
Balance at ending, shares at Sep. 30, 2022 366,074,683      
Beginning balance, value at Jun. 30, 2022 $ 358,928 118,193,072 (123,066,000) (4,514,000)
Balance at beginning, shares at Jun. 30, 2022 358,926,888      
Common stock issued on conversion of notes payable $ 1,564 12,436 14,000
Common stock issued on conversion of notes payable, shares 1,563,967      
Warrants issued with convertible notes 283,000 283,000
Common stock issued on exercise of warrants $ 5,334 202,666 208,000
Common stock issued on exercise of warrants, shares 5,333,828      
Fair value of options and warrants issued as compensation 4,000 4,000
Common stock issued on exercise of options $ 250 19,750 20,000
Common stock issued on exercise of options, shares 250,000      
Net loss (437,000) (437,000)
Ending balance, value at Sep. 30, 2022 $ 366,076 $ 118,714,924 $ (123,503,000) $ (4,422,000)
Balance at ending, shares at Sep. 30, 2022 366,074,683